Bonevia
The global market is shifting from traditional Cobalt-Chrome to advanced Highly Cross-Linked Polyethylene (HXLPE) and Ceramic-on-Ceramic interfaces, reducing wear rates by up to 90%.
The aging population in Europe and North America, combined with the rising middle class in Asia, has pushed the hip replacement market to a projected $12 Billion by 2028.
Factories are now integrating 3D Metal Printing (SLM/EBM) for porous acetabular cups, ensuring better osseointegration compared to traditional coating methods.
Bonevia Orthopedic Technology Co., Ltd., established in 2015, stands as a pillar of reliability in the joint reconstruction sector. Serving hospitals and clinics across Europe, Southeast Asia, the Middle East, and South America, we combine strict quality management (35-professional QA team) with a massive supply chain of 850+ partners. Our OEM/ODM capabilities allow for bespoke clinical solutions that meet rigorous international medical device standards.
Developing implants specifically optimized for Robotic-Assisted Surgery (RAS), ensuring sub-millimeter placement accuracy and improved patient outcomes.
Researching hydroxyapatite (HA) and silver-ion antibacterial coatings to eliminate post-operative infections and accelerate bone growth.
The next frontier includes embedded micro-sensors to monitor load distribution and potential wear in real-time, transmitted via 5G to clinics.
We primarily utilize medical-grade Titanium Alloy (Ti6Al4V) and Cobalt-Chromium-Molybdenum (CoCrMo) for their excellent biocompatibility and high fatigue strength.
Our process involves three layers of inspection: Incoming Material Verification, In-Process QC (IPQC), and Final Product Testing using CMM and surface roughness testers.
Yes, with a team of 85 R&D engineers, Bonevia provides full OEM and ODM services, translating clinical requirements into manufactured surgical solutions.
Standard components usually ship within 4-6 weeks, while complex custom OEM designs may take 8-12 weeks depending on the regulatory verification required.